학술논문
전자자료 공정이용 안내
우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.
공정이용 지침
- 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
- 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
- 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
- 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
- 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
- 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
- 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
- 상업적·영리적 목적으로 자료를 전송·복제·활용
- ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
- EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
- 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
- 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
- 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문'
에서 검색결과 587건 | 목록
1~20
Academic Journal
Pulido, I.; García-Cañaveras, J.C.; Rodríguez, M.L.; Becker, J.H.; López, A.; Aupí, M.; Aparisi, S.; Chuliá-Peris, L.; Tamayo-Torres, E.; Carreres-Rey, C.; Alcácer Fernández-Coronado, J.; Benet, M.; Montero, S.; Mena, S.; Sandoval, J.; Pereda, J.; Alcácer, J.; Calabuig-Fariñas, S.; Jantus-Lewintre, E.; Cremades, A.; Galbis-Caravajal, J.M.; Martín-Martorell, P.; Insa, A.; Massad, Malek G.; Juan-Vidal, O.; Lahoz, A.; Shimamura, T.; Carretero, J.
Cancer Letters. 633
Academic Journal
González-Cao M; Cai X; Bracht JWP; Han X; Yang Y; Pedraz-Valdunciel C; Morán T; García-Corbacho J; Aguilar A; Bernabé R; De Marchi P; Sussuchi da Silva L; Leal LF; Reis RM; Codony-Servat J; Jantus-Lewintre E; Molina-Vila MA; Cao P; Rosell R
Lung Cancer: Targets and Therapy, Vol 15, Pp 55-67 (2024)
Academic Journal
Álvarez-Pérez JC; Gene Expression Regulation and Cancer Group (CTS-993). GENYO. Centre for Genomics and Oncological Research: Pfizer-University of Granada-Andalusian Regional Government, Granada, Spain.; Department of Biochemistry and Molecular Biology I, Faculty of Sciences, University of Granada, Granada, Spain.; Instituto de Investigación Biosanitaria ibs, Granada, Spain.; Sanjuán-Hidalgo J; Gene Expression Regulation and Cancer Group (CTS-993). GENYO. Centre for Genomics and Oncological Research: Pfizer-University of Granada-Andalusian Regional Government, Granada, Spain.; Department of Biochemistry and Molecular Biology I, Faculty of Sciences, University of Granada, Granada, Spain.; Arenas AM; Gene Expression Regulation and Cancer Group (CTS-993). GENYO. Centre for Genomics and Oncological Research: Pfizer-University of Granada-Andalusian Regional Government, Granada, Spain.; Department of Biochemistry and Molecular Biology I, Faculty of Sciences, University of Granada, Granada, Spain.; Instituto de Investigación Biosanitaria ibs, Granada, Spain.; Hernández-Navas I; Targeted Therapies for Precision Oncology, Instituto de Investigación Hospital 12 de Octubre (i+12), CIBERONC, Madrid, Spain.; H12O-CNIO Lung Cancer Clinical Research Unit, Instituto de Investigación Hospital 12 de Octubre (i+12) & Centro Nacional de Investigaciones Oncológicas (CNIO), CIBERONC, UCM, Madrid, Spain.; Benitez-Cantos MS; Gene Expression Regulation and Cancer Group (CTS-993). GENYO. Centre for Genomics and Oncological Research: Pfizer-University of Granada-Andalusian Regional Government, Granada, Spain.; Instituto de Investigación Biosanitaria ibs, Granada, Spain.; Department of Biochemistry and Molecular Biology III, Faculty of Medicine, University of Granada, Granada, Spain.; Andrades A; Gene Expression Regulation and Cancer Group (CTS-993). GENYO. Centre for Genomics and Oncological Research: Pfizer-University of Granada-Andalusian Regional Government, Granada, Spain.; Department of Biochemistry and Molecular Biology I, Faculty of Sciences, University of Granada, Granada, Spain.; Instituto de Investigación Biosanitaria ibs, Granada, Spain.; Calabuig-Fariñas S; Department of Pathology, Universitat de Valencia, Valencia, Spain.; Molecular Oncology Lab, Fundación para la Investigación del Hospital General Universitario de Valencia; CIBERONC, Valencia, Spain.; Jantus-Lewintre E; Molecular Oncology Lab, Fundación para la Investigación del Hospital General Universitario de Valencia; CIBERONC, Valencia, Spain.; Department of Biotechnology, Joint Unit UPV-CIPF Nanomedicine and Disease Mechanisms. Universitat Politècnica de València and Centro de Investigación Príncipe Felipe, Valencia, Spain.; Paz-Ares L; H12O-CNIO Lung Cancer Clinical Research Unit, Instituto de Investigación Hospital 12 de Octubre (i+12) & Centro Nacional de Investigaciones Oncológicas (CNIO), CIBERONC, UCM, Madrid, Spain.; Ferrer I; Targeted Therapies for Precision Oncology, Instituto de Investigación Hospital 12 de Octubre (i+12), CIBERONC, Madrid, Spain.; H12O-CNIO Lung Cancer Clinical Research Unit, Instituto de Investigación Hospital 12 de Octubre (i+12) & Centro Nacional de Investigaciones Oncológicas (CNIO), CIBERONC, UCM, Madrid, Spain.; Medina PP; Gene Expression Regulation and Cancer Group (CTS-993). GENYO. Centre for Genomics and Oncological Research: Pfizer-University of Granada-Andalusian Regional Government, Granada, Spain. pedromedina@ugr.es.; Department of Biochemistry and Molecular Biology I, Faculty of Sciences, University of Granada, Granada, Spain. pedromedina@ugr.es.; Instituto de Investigación Biosanitaria ibs, Granada, Spain. pedromedina@ugr.es.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Academic Journal
Herreros-Pomares, A; Doria, P; Gallach, S; Meri-Abad, M; Guijarro, R; Calabuig-Farinas, S; Camps, C; Jantus-Lewintre, E
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Universitat Politècnica de València (UPV)
ANNALS OF SURGICAL ONCOLOGY
r-FIHGUV. Repositorio Institucional de Producción Científica de la Fundación de Investigación del Hospital General de Valencia
Fundación de Investigación del Hospital General de Valencia (FIHGUV)
r-CIPF. Repositorio Institucional Producción Científica del Centro de Investigación Principe Felipe (CIPF)
Universitat Rovira i virgili (URV)
Centro de Investigación Principe Felipe (CIPF)
Universitat Politècnica de València (UPV)
ANNALS OF SURGICAL ONCOLOGY
r-FIHGUV. Repositorio Institucional de Producción Científica de la Fundación de Investigación del Hospital General de Valencia
Fundación de Investigación del Hospital General de Valencia (FIHGUV)
r-CIPF. Repositorio Institucional Producción Científica del Centro de Investigación Principe Felipe (CIPF)
Universitat Rovira i virgili (URV)
Centro de Investigación Principe Felipe (CIPF)
Editorial & Opinion
Jantus-Lewintre E; Instituto Interuniversitario de Investigación de Reconocimiento Molecular y Desarrollo Tecnológico (IDM), Universitat Politècnica de València, Universitat de València, Valencia, Spain; Unidad Mixta UPV-CIPF de Investigación en Mecanismos de Enfermedades y Nanomedicina, Universitat Politècnica de València, Centro de Investigación Príncipe Felipe, Valencia, Spain; Molecular Oncology Laboratory, General University Hospital Research Foundation, Valencia, Spain; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), ISCIII, Madrid, Spain.; Patiño-García A; Medical Genetics Unit, Cancer Center Clínica Universidad de Navarra; Laboratory of Advanced Therapies for Pediatric Solid Tumors, Solid Tumor Program, Cancer Division, Center for Applied Medical Research, Cima; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.; Díaz-Lagares A; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), ISCIII, Madrid, Spain; Epigenomics Unit, Cancer Epigenomics, Translational Medical Oncology Group (ONCOMET), Health Research Institute of Santiago de Compostela (IDIS), University Clinical Hospital of Santiago (CHUS/SERGAS), Santiago de Compostela, Spain; Department of Clinical Analysis, University Hospital Complex of Santiago de Compostela (CHUS), Santiago de Compostela, Spain. Electronic address: angel.diaz.lagares@sergas.es.
Publisher: Elsevier Country of Publication: United States NLM ID: 101274235 Publication Model: Print Cited Medium: Internet ISSN: 1556-1380 (Electronic) Linking ISSN: 15560864 NLM ISO Abbreviation: J Thorac Oncol Subsets: MEDLINE; In Process
Academic Journal
Patiño-García, A. (Ana); Guruceaga, E. (Elizabeth); Ocón-De-Miguel, M.M. (María M.); Sokoudjou, J.F. (Junior Fodop); Villalonga-Zornoza, N. (Nicolás de); Alkorta-Aranburu, G. (Gorka); Tamayo-Uria, I. (Ibon); Gurpide, A. (Alfonso); Camps, C. (Carlos); Jantus-Lewintre, E. (Eloisa); Navamuel-Andueza, M. (María); Fernandez-Sanmamed, M. (Miguel); Melero, I. (Ignacio); Elgendy, M. (Mohamed); Fusco, J.P. (Juan Pablo); Zulueta, J. (Javier); Torres, J.P. (Juan P.) de; Bastarrika, G. (Gorka); Seijo, L. (Luis); Pio, R. (Rubén); Montuenga-Badia, L.M. (Luis M.); Hernaez, M. (Mikel); Perez-Gracia, J.L. (Jose Luis); Ochoa-Álvarez, I. (Idoia)
Dadun. Depósito Académico Digital de la Universidad de Navarra
Universidad de Navarra
Universidad de Navarra
Academic Journal
González-Cao, Maria; Cai, Xueting; Paulina Bracht, Jilian Wilhelmina; Han, Xuan; Yang, Yang; Pedraz-Valdunciel, Carlos; Morán, Teresa; García-Corbacho, Javier; Aguilar, Andrés; Bernabé, Reyes; De Marchi, Pedro; da Silva, L.S.; Leal, L.F.; Reis, R.M.; Codony-Servat, Jordi; Jantus-Lewintre, E.; Molina-Vila, M.A.; Cao, P.; Rosell, Rafael; Universitat Autònoma de Barcelona
Academic Journal
Manuel, A. Moreno; Torres-Martínez, S.; Boada, A.; Bellón, M.; Escorihuela, E.; Calabuig-Fariñas, S.; Sirera, R.; Camps, C.; Blasco, A.; Jantus-Lewintre, E.
The Journal of Liquid Biopsy. 1
KRAS-mutant non-small cell lung cancer (NSCLC) therapy based on tepotinib and omeprazole combination
Academic Journal
Rosell, Rafael; Jantus-Lewintre, E.; Cao, P.; Cai, X.; Xing, B.; Ito, Masaoki; Gomez-Vazquez, Jose Luis; Marco-Jordán, Mireia; Calabuig-Fariñas, S.; Cardona, A.F.; Codony-Servat, Jordi; Gonzalez, Jessica; València-Clua, Kevin; Aguilar, A.; Pedraz-Valdunciel, C.; Dantes, Z.; Jain, A.; Chandan, S.; Molina-Vila, M.A.; Arrieta, O.; Ferrero, M.; Camps, C.; González-Cao, M.; Universitat Autònoma de Barcelona
Academic Journal
Torres-Martínez, S.; Fernández, A.; Carbonell, J.; Escorihuela, E.; Juciute, N.; Ramos, I.; Berrocal, A.; Jantus-Lewintre, E.; Camps, C.; Calabuig-Fariñas, S.
The Journal of Liquid Biopsy. 1
Academic Journal
Munera-Maravilla, E.; Moya, C. Ortuño; Gallach, S.; Labrandero, C.; Moreno-Manuel, A.; Bellón-Robles, M.; Calabuig-Fariñas, S.; Esteve-Martínez, A.; Jantus-Lewintre, E.
The Journal of Liquid Biopsy. 1
Academic Journal
Garcia, S. Gallach; Mosqueda, M.; Moreno-Manuel, A.; Navarro, L.; Torres-Martínez, S.; Munera-Maravilla, E.; Blasco, A.; Calabuig-Fariñas, S.; Camps, C.; Jantus-Lewintre, E.
The Journal of Liquid Biopsy. 1
Academic Journal
Manuel, A. Moreno; Dong, N.; Gallach, S.; Torres-Martínez, S.; Mosqueda, M.; Calabuig-Fariñas, S.; Sirera, R.; Blasco, A.; Camps, C.; Jantus-Lewintre, E.
The Journal of Liquid Biopsy. 1
Conference
Rosell, R; Jain, A; Codony-Servat, J; Shivamallu, C; Kollur, SP; Prasad, A; Jantus-Lewintre, E; Ito, M; Cardona, AF; Arrieta, O; Cao, P; Cai, X; Xing, B; Pedraz-Valdunciel, C; Dantes, Z; Sullivan, I; Aguilar, A; Molina-Vila, MA; González-Cao, M
Journal of Thoracic Oncology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Institut de Recerca Germans Trias i Pujol (IGTP)
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Institut de Recerca Germans Trias i Pujol (IGTP)
Academic Journal
García-Fernández J; Nano-Oncology and Translational Therapeutics group, Health Research Institute of Santiago de Compostela (IDIS), Complexo Hospitalario Universitario de Santiago de Compostela (SERGAS), 15706 Santiago de Compostela, Spain.; Díez-Villares S; Nano-Oncology and Translational Therapeutics group, Health Research Institute of Santiago de Compostela (IDIS), Complexo Hospitalario Universitario de Santiago de Compostela (SERGAS), 15706 Santiago de Compostela, Spain; Biomedical Research Networking Center on Oncology (CIBERONC), Madrid 28029, Spain; Universidade de Santiago de Compostela (USC), Santiago de Compostela 15706, Spain.; Cascallar M; Nano-Oncology and Translational Therapeutics group, Health Research Institute of Santiago de Compostela (IDIS), Complexo Hospitalario Universitario de Santiago de Compostela (SERGAS), 15706 Santiago de Compostela, Spain; Biomedical Research Networking Center on Oncology (CIBERONC), Madrid 28029, Spain; Universidade de Santiago de Compostela (USC), Santiago de Compostela 15706, Spain.; Rivadulla Costa L; Nano-Oncology and Translational Therapeutics group, Health Research Institute of Santiago de Compostela (IDIS), Complexo Hospitalario Universitario de Santiago de Compostela (SERGAS), 15706 Santiago de Compostela, Spain; Universidade de Santiago de Compostela (USC), Santiago de Compostela 15706, Spain.; Martins AS; Medical Devices Research Group, International Iberian Nanotechnology Laboratory (INL), Avenida Mestre José Veiga, 4715-330 Braga, Portugal.; Groba de Antas S; Nano-Oncology and Translational Therapeutics group, Health Research Institute of Santiago de Compostela (IDIS), Complexo Hospitalario Universitario de Santiago de Compostela (SERGAS), 15706 Santiago de Compostela, Spain; Universidade de Santiago de Compostela (USC), Santiago de Compostela 15706, Spain.; Tarasco MC; Unit of Epigenomics and Biomarkers of Solid Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Pantano E; Unit of Epigenomics and Biomarkers of Solid Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Taiè G; Unit of Epigenomics and Biomarkers of Solid Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Bertolini G; Unit of Epigenomics and Biomarkers of Solid Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; García-Hernández M; IRYCIS-Hospital Ramón y Cajal, Madrid, Spain.; Moreno M; IRYCIS-Hospital Ramón y Cajal, Madrid, Spain; Aptus Biotech S.L., Madrid, Spain.; Martín ME; IRYCIS-Hospital Ramón y Cajal, Madrid, Spain.; Munera-Maravilla E; Biomedical Research Networking Center on Oncology (CIBERONC), Madrid 28029, Spain; Molecular Oncology Laboratory, General University Hospital Research Foundation, Valencia 46014, Spain; Trial Mixed Unit, Centro Investigación Príncipe Felipe-Fundación Investigación Hospital General Universitario de Valencia, Valencia, Spain.; Calabuig-Fariñas S; Biomedical Research Networking Center on Oncology (CIBERONC), Madrid 28029, Spain; Molecular Oncology Laboratory, General University Hospital Research Foundation, Valencia 46014, Spain; Trial Mixed Unit, Centro Investigación Príncipe Felipe-Fundación Investigación Hospital General Universitario de Valencia, Valencia, Spain; Department of Pathology, Universitat de Valéncia, Valencia, Spain.; Taina-González L; Nano-Oncology and Translational Therapeutics group, Health Research Institute of Santiago de Compostela (IDIS), Complexo Hospitalario Universitario de Santiago de Compostela (SERGAS), 15706 Santiago de Compostela, Spain; DIVERSA Technologies S.L, Santiago de Compostela, Spain.; G Blanco M; Universidade de Santiago de Compostela (USC), Santiago de Compostela 15706, Spain; DNA Repair and Genome Integrity, Centre for Research in Molecular Medicine and Chronic Diseases (CIMUS), Universidade de Santiago de Compostela, Santiago de Compostela, Spain.; López-López R; Biomedical Research Networking Center on Oncology (CIBERONC), Madrid 28029, Spain; Translational Medical Oncology Group (Oncomet), Health Research Institute of Santiago de Compostela (IDIS), Complexo Hospitalario Universitario de Santiago de Compostela (SERGAS), 15706 Santiago de Compostela, Spain.; Ainla A; Medical Devices Research Group, International Iberian Nanotechnology Laboratory (INL), Avenida Mestre José Veiga, 4715-330 Braga, Portugal.; Abalde-Cela S; Medical Devices Research Group, International Iberian Nanotechnology Laboratory (INL), Avenida Mestre José Veiga, 4715-330 Braga, Portugal.; Gonçalves C; Medical Devices Research Group, International Iberian Nanotechnology Laboratory (INL), Avenida Mestre José Veiga, 4715-330 Braga, Portugal.; Xavier M; Medical Devices Research Group, International Iberian Nanotechnology Laboratory (INL), Avenida Mestre José Veiga, 4715-330 Braga, Portugal.; Diéguez L; Medical Devices Research Group, International Iberian Nanotechnology Laboratory (INL), Avenida Mestre José Veiga, 4715-330 Braga, Portugal.; Jantus-Lewintre E; Biomedical Research Networking Center on Oncology (CIBERONC), Madrid 28029, Spain; Molecular Oncology Laboratory, General University Hospital Research Foundation, Valencia 46014, Spain; Department of Biotechnology, Universitat Politècnica de València, Camí de Vera s/n, Valencia 46022, Spain; Joint Unit: Nanomedicine, Centro Investigación Príncipe Felipe-Universitat Politècnica de Valencia, Valencia, Spain.; Roz L; Unit of Epigenomics and Biomarkers of Solid Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; González VM; IRYCIS-Hospital Ramón y Cajal, Madrid, Spain; Aptus Biotech S.L., Madrid, Spain.; de la Fuente Freire M; Nano-Oncology and Translational Therapeutics group, Health Research Institute of Santiago de Compostela (IDIS), Complexo Hospitalario Universitario de Santiago de Compostela (SERGAS), 15706 Santiago de Compostela, Spain; Biomedical Research Networking Center on Oncology (CIBERONC), Madrid 28029, Spain; DIVERSA Technologies S.L, Santiago de Compostela, Spain. Electronic address: Maria.De.La.Fuente.Freire@sergas.es.
Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 8607908 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-4995 (Electronic) Linking ISSN: 01683659 NLM ISO Abbreviation: J Control Release Subsets: MEDLINE
Academic Journal
Meri-Abad M; Moreno-Manuel A; García SG; Calabuig-Fariñas S; Pérez RS; Herrero CC; Jantus-Lewintre E
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
r-CIPF. Repositorio Institucional Producción Científica del Centro de Investigación Principe Felipe (CIPF)
Centro de Investigación Principe Felipe (CIPF)
r-CIPF. Repositorio Institucional Producción Científica del Centro de Investigación Principe Felipe (CIPF)
Centro de Investigación Principe Felipe (CIPF)
Academic Journal
Jantus-Lewintre E; Fundación Investigación Hospital General Universitario de València, Universitat Politècnica de València, CIBERONC, Valencia, Spain.; Rappa A; Istituto Europeo di Oncologia, IRCCS, Via Adamello 16, 20139, Milan, Italy.; Ruano D; Leiden University Medical Center, Leiden, The Netherlands.; van Egmond D; Leiden University Medical Center, Leiden, The Netherlands.; Gallach S; Fundación Investigación Hospital General Universitario de València, Universitat Politècnica de València, CIBERONC, Valencia, Spain.; Gozuyasli D; Thermo Fisher Scientific, Waltham, MA, USA.; Durães C; Thermo Fisher Scientific, Waltham, MA, USA.; Costa JL; Thermo Fisher Scientific, Waltham, MA, USA.; Camps C; Consorcio Hospital General Universitario de València, Universitat de València, CIBERONC, Valencia, Spain.; Lacroix L; Institut Gustave Roussy, Paris, France.; Kashofer K; Medical University of Graz, Graz, Austria.; van Wezel T; Leiden University Medical Center, Leiden, The Netherlands.; Netherlands Cancer Institute, Amsterdam, The Netherlands.; Barberis M; Istituto Europeo di Oncologia, IRCCS, Via Adamello 16, 20139, Milan, Italy. massimo.barberis@ieo.it.
Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 101264260 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-2000 (Electronic) Linking ISSN: 11771062 NLM ISO Abbreviation: Mol Diagn Ther Subsets: MEDLINE
Academic Journal
Herreros-Pomares, A; Doria, P; Gallach, S; Meri-Abad, M; Guijarro, R; Calabuig-Fariñas, S; Camps, C; Jantus-Lewintre, E
ANNALS OF SURGICAL ONCOLOGY
r-FIHGUV. Repositorio Institucional de Producción Científica de la Fundación de Investigación del Hospital General de Valencia
Fundación de Investigación del Hospital General de Valencia (FIHGUV)
r-FIHGUV. Repositorio Institucional de Producción Científica de la Fundación de Investigación del Hospital General de Valencia
Fundación de Investigación del Hospital General de Valencia (FIHGUV)
Academic Journal
Exposito F; Program in Solid Tumors, Cima-Universidad de Navarra, Cancer Center Clinica Universidad de Navarra (CCUN), Pamplona, Spain.; CIBERONC, ISCIII, Madrid, Spain.; IDISNA, Pamplona, Spain.; Department of Pathology, Anatomy and Physiology, School of Medicine, University of Navarra, Pamplona, Spain.; Yale Cancer Center, New Haven, CT, USA.; Redrado M; Program in Solid Tumors, Cima-Universidad de Navarra, Cancer Center Clinica Universidad de Navarra (CCUN), Pamplona, Spain.; IDISNA, Pamplona, Spain.; Serrano D; Program in Solid Tumors, Cima-Universidad de Navarra, Cancer Center Clinica Universidad de Navarra (CCUN), Pamplona, Spain.; CIBERONC, ISCIII, Madrid, Spain.; IDISNA, Pamplona, Spain.; Department of Pathology, Anatomy and Physiology, School of Medicine, University of Navarra, Pamplona, Spain.; Calabuig-Fariñas S; CIBERONC, ISCIII, Madrid, Spain.; Molecular Oncology Laboratory, Fundación Hospital General Universitario de Valencia, 46014, Valencia, Spain.; TRIAL Mixed Unit, Centro de Investigación Príncipe Felipe-Fundación para la Investigación del Hospital General Universitario de Valencia, 46014, Valencia, Spain.; Department of Pathology, Universitat de València, 46010, Valencia, Spain.; Bao-Caamano A; Epigenomics Units, Cancer Epigenomics, Translational Medical Oncology Group (ONCOGAL), Health Research Institute of Santiago de Compostela (IDIS), and Department of Clinical Analysis, University Hospital Complex of Santiago de Compostela (CHUS), Roche-CHUS Joint Unit (ONCOMET), Health Research Institute of Santiago (IDIS), 15706, Santiago de Compostela, Spain, 15706, Santiago de Compostela, Spain.; Gallach S; CIBERONC, ISCIII, Madrid, Spain.; Molecular Oncology Laboratory, Fundación Hospital General Universitario de Valencia, 46014, Valencia, Spain.; TRIAL Mixed Unit, Centro de Investigación Príncipe Felipe-Fundación para la Investigación del Hospital General Universitario de Valencia, 46014, Valencia, Spain.; Jantus-Lewintre E; CIBERONC, ISCIII, Madrid, Spain.; Molecular Oncology Laboratory, Fundación Hospital General Universitario de Valencia, 46014, Valencia, Spain.; TRIAL Mixed Unit, Centro de Investigación Príncipe Felipe-Fundación para la Investigación del Hospital General Universitario de Valencia, 46014, Valencia, Spain.; Department of Biotechnology, Universitat Politècnica de València, 46022, Valencia, Spain.; Diaz-Lagares A; CIBERONC, ISCIII, Madrid, Spain.; Epigenomics Units, Cancer Epigenomics, Translational Medical Oncology Group (ONCOGAL), Health Research Institute of Santiago de Compostela (IDIS), and Department of Clinical Analysis, University Hospital Complex of Santiago de Compostela (CHUS), Roche-CHUS Joint Unit (ONCOMET), Health Research Institute of Santiago (IDIS), 15706, Santiago de Compostela, Spain, 15706, Santiago de Compostela, Spain.; Rodriguez-Casanova A; Epigenomics Units, Cancer Epigenomics, Translational Medical Oncology Group (ONCOGAL), Health Research Institute of Santiago de Compostela (IDIS), and Department of Clinical Analysis, University Hospital Complex of Santiago de Compostela (CHUS), Roche-CHUS Joint Unit (ONCOMET), Health Research Institute of Santiago (IDIS), 15706, Santiago de Compostela, Spain, 15706, Santiago de Compostela, Spain.; Sandoval J; Biomarkers and Precision Medicine (UBMP) and Epigenomics Unit, IIS, La Fe, 46026, Valencia, Spain.; San Jose-Eneriz E; CIBERONC, ISCIII, Madrid, Spain.; IDISNA, Pamplona, Spain.; Division of Hemato-Oncology, Cima-Universidad de Navarra, Cancer Center Clinica Universidad de Navarra (CCUN), Pamplona, Spain.; Garcia J; Department of Pathology, Anatomy and Physiology, School of Medicine, University of Navarra, Pamplona, Spain.; Redin E; Program in Solid Tumors, Cima-Universidad de Navarra, Cancer Center Clinica Universidad de Navarra (CCUN), Pamplona, Spain.; CIBERONC, ISCIII, Madrid, Spain.; IDISNA, Pamplona, Spain.; Department of Pathology, Anatomy and Physiology, School of Medicine, University of Navarra, Pamplona, Spain.; Senent Y; Program in Solid Tumors, Cima-Universidad de Navarra, Cancer Center Clinica Universidad de Navarra (CCUN), Pamplona, Spain.; Department of Biochemistry and Genetics, School of Sciences, University of Navarra, Pamplona, Spain.; Leon S; Program in Solid Tumors, Cima-Universidad de Navarra, Cancer Center Clinica Universidad de Navarra (CCUN), Pamplona, Spain.; CIBERONC, ISCIII, Madrid, Spain.; Pio R; Program in Solid Tumors, Cima-Universidad de Navarra, Cancer Center Clinica Universidad de Navarra (CCUN), Pamplona, Spain.; CIBERONC, ISCIII, Madrid, Spain.; Department of Biochemistry and Genetics, School of Sciences, University of Navarra, Pamplona, Spain.; Lopez R; CIBERONC, ISCIII, Madrid, Spain.; Epigenomics Units, Cancer Epigenomics, Translational Medical Oncology Group (ONCOGAL), Health Research Institute of Santiago de Compostela (IDIS), and Department of Clinical Analysis, University Hospital Complex of Santiago de Compostela (CHUS), Roche-CHUS Joint Unit (ONCOMET), Health Research Institute of Santiago (IDIS), 15706, Santiago de Compostela, Spain, 15706, Santiago de Compostela, Spain.; Oyarzabal J; Molecular Therapeutics Program, CIMA, CCUN, University of Navarra, Pamplona, Spain.; Pineda-Lucena A; Molecular Therapeutics Program, CIMA, CCUN, University of Navarra, Pamplona, Spain.; Agirre X; CIBERONC, ISCIII, Madrid, Spain.; IDISNA, Pamplona, Spain.; Division of Hemato-Oncology, Cima-Universidad de Navarra, Cancer Center Clinica Universidad de Navarra (CCUN), Pamplona, Spain.; Montuenga LM; Program in Solid Tumors, Cima-Universidad de Navarra, Cancer Center Clinica Universidad de Navarra (CCUN), Pamplona, Spain.; CIBERONC, ISCIII, Madrid, Spain.; IDISNA, Pamplona, Spain.; Department of Pathology, Anatomy and Physiology, School of Medicine, University of Navarra, Pamplona, Spain.; Prosper F; CIBERONC, ISCIII, Madrid, Spain.; IDISNA, Pamplona, Spain.; Hematology and Cell Therapy Service, Cancer Center Clinica Universidad de Navarra (CCUN), Pamplona, Spain.; Calvo A; Program in Solid Tumors, Cima-Universidad de Navarra, Cancer Center Clinica Universidad de Navarra (CCUN), Pamplona, Spain. acalvo@unav.es.; CIBERONC, ISCIII, Madrid, Spain. acalvo@unav.es.; IDISNA, Pamplona, Spain. acalvo@unav.es.; Department of Pathology, Anatomy and Physiology, School of Medicine, University of Navarra, Pamplona, Spain. acalvo@unav.es.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101524092 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-4889 (Electronic) NLM ISO Abbreviation: Cell Death Dis Subsets: MEDLINE
Academic Journal
Zugazagoitia, J. ; Ramos, I. ; Trigo, J.M. ; Palka, M. ; Gómez-Rueda, A. ; Jantus-Lewintre, E. ; Camps, C. ; Isla, D. ; Iranzo, P. ; Ponce-Aix, S. ; García-Campelo, R. ; Provencio, M. ; Franco, F. ; Bernabé, R. ; Juan-Vidal, O. ; Felip, E. ; de Castro, J. ; Sanchez-Torres, J.M. ; Faul, I. ; Lanman, R.B. ; Garrido, P. ; Paz-Ares, L.
In Annals of Oncology February 2019 30(2):290-296
검색 결과 제한하기
제한된 항목
[검색어] Jantus Lewintre, E.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어